Australian biotech market today 26.03.09
Thursday, 26 March, 2009
The pharma and biotech index is up 2.35 per cent at 3.00pm on a generally positive day for the share market.
Cochlear (ASX:COH) is up 63c and CSL (ASX:CSL) is up 79c, while Resmed (ASX:RMD) has had smaller gains.
Progen (ASX:PGL) is up a bit on news of its share buyback. Alchemia (ASX:ACL) is up a touch to 29c and Genera Biosystems (ASX:GBI) is up 5c, both on the back of new share options.
Peplin (ASX:PLI) is up 4c on small trades while Sonic Healthcare (ASX:SHL) is up a cent to $11.32.
ChemGenex (ASX:CXS) is down slightly, as is Novogen (ASX:NRT).
Babies of stressed mothers likely to get their teeth earlier
Maternal stress during pregnancy can speed up the timing of teeth eruption, which may be an early...
Customised immune cells used to fight brain cancer
Researchers have developed CAR-T cells — ie, genetically modified immune cells manufactured...
Elevated blood protein levels predict mortality
Proteins that play key roles in the development of diseases such as cancer and inflammation may...
